Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils

Blood

Volumn 91, Issue 5, 1998, Pages 1527-1532

  Dunzendorfer, Stefan ^a   Schratzberger, Peter ^a   Reinisch, Norbert ^a   Kähler, Christian M ^a   Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CHEMOATTRACTANT; INTERLEUKIN 8; ISOBUTYLMETHYLXANTHINE; NEUROPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D; PROTEIN KINASE INHIBITOR; SECRETONEURIN; STAUROSPORINE; SUBSTANCE P; TYRPHOSTIN; WORTMANNIN;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; ENZYME ACTIVATION; ENZYME INHIBITION; EOSINOPHIL; GRANULOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032032269     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.5.1527.1527_1527_1532     Document Type: Article

References (34)

1. Hökfelt T, Kellerth JO, Nilsson G, Pernow B: Substance P: Localization in the central nervous system and in some primary sensory neurons. Science 190:889, 1975
2. Payan DG: Neuropeptides and inflammation: The role of substance P. Annu Rev Med 40:341, 1989
3. Goetzl EJ, Adelman DC, Sreedharan SP: Neuroimmunology. Adv Immunol 48:161, 1990
4. Kirchmair R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H: Secretoneurin - A neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 53:359, 1993
5. Kirchmair R, Marksteiner J, Troger J, Mahata SK, Mahata M, Donnerer J, Amann R, Fischer-Colbrie R, Winkler H, Saria A: Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide. Eur J Neurosci 6:861, 1994
6. Reinisch N, Kirchmair R, Kähler CM, Hogue-Angeletti R, Fischer-Colbrie R, Winkler H, Wiedermann CJ: Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett 334:41, 1993
7. Schratzberger P, Reinisch N, Prodinger WM, Kähler CM, Sitte BA, Bellmann R, Fischer-Colbrie R, Winkler H, Wiedermann CJ: Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 158:3895, 1997
8. Schratzberger P, Reinisch N, Kähler CM, Wiedermann CJ: Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin. Regul Pept 63:65, 1996
9. Kähler CM, Bellmann R, Reinisch N, Schratzberger P, Gruber B, Wiedermann CJ: Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin. Eur J Pharmacol 304:135, 1996
10. Shute J: Interleukin-8 is a potent eosinophil chemo-attractant. Clin Exp Allergy 24:203, 1994
11. Wiedermann FJ, Kähler CM, Reinisch N, Wiedermann CJ: Induction of normal human eosinophil migration in vitro by substance P. Acta Haematol 89:213, 1993
12. Numao T, Agrawal DK: Neuropeptides modulate human eosinophil chemotaxis. J Immunol 149:3309, 1992
13. Schwenk U, Schroder JM: 5-Oxo-eicosanoids are potent eosinophil chemotactic factors. Functional characterization and structural requirements. J Biol Chem 270:15029, 1995
14. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP: Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 153:2153, 1994
15. Wiedermann CJ, Niedermühlbichler M, Braunsteiner H: Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J Clin Invest 89:1580, 1992
16. Powell WS, Chung D, Gravel S: 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J Immunol 154:4123, 1995
17. Spry CJF, Kay AB, Gleich GJ: Eosinophils. Immunol Today 13:384, 1992
18. Lee J, Ishhara A, Theriot JA, Jacobson K: Principles of locomotion for simple-shaped cells. Nature 362:167, 1993
19. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA: RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 176:1489, 1992
20. Bach MK, Brashler JR: FMLP is a potent activator of guinea-pig eosinophils but its activity is dependent on the prior overnight in vitro culture of the cells (facilitation). Immunology 75:680, 1992
21. Kitayama J, Carr MW, Roth SJ, Buccola J, Springer TA: Contrasting response to multiple chemotactic stimuli in transendothelial migration: Heterologous desensitization in neutrophils and augmentation of migration in eosinophils. J Immunol 158:2340, 1997
22. Blom M, Tool AT, Mul FP, Knol EF, Roos D, Verhoeven AJ: Eosinophils isolated with different methods show different characteristics of activation. J Immunol Methods 178:183, 1995
23. Elsner J, Hochstetter R, Kimmig D, Kapp A: Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol 26:1919, 1996
24. Kapp A, Zeck-Kapp G, Czech W, Schopf E: The chemokine RANTES is more than a chemoattractant: Characterization of its effect on human eosinophil oxidative metabolism and morphology in comperison with IL-5 and GM-CSF. J Invest Dermatol 102:906, 1994
25. Bach MK, Brashler JR, Petzold EN, Sanders ME: Superoxide production by human eosinophils can be inhibited in an agonistselective manner. Agents Actions 35:1, 1992
26. Schweizer RC, van-Kessel-Welmers BA, Warringa RA, Maikoe T, Raaijmakers JA, Lammers JW, Koenderman L: Mechanisms involved in eosinophil migration. Platelet-activating-factor-induced chemotaxis and interleukin-5-induced chemokinesis are mediated by different signals. J Leukoc Biol 59:347, 1996
27. Kaneko T, Alvarez R, Ueki IF, Nadel JA: Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Cell Signal 7:527, 1995
28. Alves AC, Pires AL, Cruz HN, Serra MF, Diaz BL, Cordeiro RS, Lagente V, Martins MA: Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. Eur J Pharmacol 312:89, 1996
29. Thelen M, Uguccioni M, Bosiger J: PI 3-kinase-dependent and independent chemotaxis of human neutrophil leukocytes. Biochem Biophys Res Commun 217:1255, 1995
30. Hatzelmann A, Tenor H, Schudt C: Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil function. Br J Pharmacol 114:821, 1995
31. Kaminuma O, Kikkawa H, Matsubara S, Ikezawa K: Effect of T-440, a novel type IV phosphodiesterase inhibitor, on allergen-induced immediate and late asthmatic reaction and leukocyte infiltration into the airways of guinea pigs. Int Arch Allergy Immunol 112:406, 1997
32. Torphy TJ, Barnette MS, Hay DW, Underwood DC: Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma. Environ Health Perspect 102:79, 1994 (suppl 10)
33. Santamaria LF, Palacios JM, Beleta J: Inhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram. Br J Pharmacol 121:1150, 1997
34. Santing RE, Olymulder CG, Van der Molen K, Meurs H, Zaagsma J: Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol 275:75, 1995